← Health care and life sciences companies

    ALX Oncology: company profile, size and contacts

    alxoncology.comActiveFor profit

    ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.

    Employees
    11-50
    Founded
    2015
    Total raised
    $329.2M
    Monthly visits
    677

    Company facts

    Website
    alxoncology.com
    Location
    San Francisco Bay Area, West Coast, Western US
    Employees
    11-50
    Founded
    2015 (11 years ago)
    Categories
    Biopharma, Biotechnology, Health Care, Life Science, Oncology, Therapeutics
    Company type
    For profit
    Listing
    Public (NASDAQ:ALXO)
    Industry code (NAICS)
    6211 Offices of physicians; 3254 Pharmaceutical and medicine manufacturing
    Industry code (SIC)
    8000 Health services; 2834 Pharmaceutical preparations

    Founder

    • Jaume PonsFounder · ALX Oncology

    ALX Oncology was founded in 2015 by Jaume Pons.

    Funding

    Total raised
    $329.2M
    Funding rounds
    6
    Latest round
    Post ipo equity, 2023-10
    Investors
    12
    Lead investors
    5
    Acquisitions made
    1

    Web and app presence

    Monthly website visits
    677
    Global traffic rank
    #7,885,816

    How ALX Oncology compares

    • Size: ALX Oncology has more employees than 15% of the 1251 health care and life sciences companies in our directory that report it.
    • Age: ALX Oncology is older than 18% of the 1166 health care and life sciences companies in our directory that report it.
    • Web traffic: ALX Oncology gets more monthly website visits than 24% of the 1233 health care and life sciences companies in our directory that report it.

    1282 health care and life sciences companies are in the directory, 519 of them in the same 11-50 employee range and 43 based in San Francisco Bay Area.

    Growth outlook

    • Trend: Growing

    ALX Oncology may be growing as evidenced by the recent financial results and corporate developments reported for Q3 2023. The company has also been recognized by an investment firm, with abrdn plc acquiring a significant number of shares, indicating investor confidence. Furthermore, ALX Oncology has been actively advancing its clinical programs, as demonstrated by the initiation of a Phase 2 investigator-sponsored trial and the acceptance of clinical abstracts for presentation at major industry meetings, which suggests progress in its product development pipeline.

    What ALX Oncology says about itself

    “We’re dedicated to expanding the possibilities for patients by developing novel approaches to optimize current and future standards of care.” alxoncology.com

    ALX Oncology in short

    ALX Oncology is a biopharma company based in San Francisco Bay Area, with 11-50 employees, founded in 2015. Its founder is Jaume Pons and it has raised $329.2 million over 6 rounds.

    Frequently asked questions

    What does ALX Oncology do?
    ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.
    When was ALX Oncology founded?
    ALX Oncology was founded in 2015, so it is about 11 years old.
    How many employees does ALX Oncology have?
    Crunchbase lists ALX Oncology in the 11-50 employee range.
    Where is ALX Oncology based?
    ALX Oncology is listed under San Francisco Bay Area, West Coast, Western US.
    Has ALX Oncology raised funding?
    Crunchbase records $329.2M raised across 6 funding rounds, most recently post ipo equity in 2023-10.
    How do I find email addresses at ALX Oncology?
    Search the domain alxoncology.com with the Inbound Labs Domain Search or Email Finder to see verified contacts and departments. Individual addresses are shown after you sign up.

    Similar companies

    More in Health care and life sciences companies.

    Data sources: company facts, funding and leadership from Crunchbase; website traffic estimates from Semrush (latest month); company website, checked 2026-11-10; industry codes from the US NAICS and SIC lists; comparisons calculated from the profiles in this directory.